Moyamoya syndrome associated with sickle cell trait in a child

Mustafa Komur1, Selma Unal2, Cetin Okuyaz1

  • 1Mersin University School of Medicine, Department of Pediatric Neurology, Turkey.

Brain & Development
|August 20, 2013
PubMed

Insights

Moyamoya syndrome, a cerebrovascular condition, can occur with sickle cell trait. This case report details the first child diagnosed with moyamoya syndrome associated with sickle cell trait, highlighting a rare but significant association.

Area of Science:

  • Neurology
  • Hematology
  • Pediatric Medicine

Background:

  • Moyamoya syndrome is a progressive cerebrovascular disease characterized by arterial occlusion and collateral vessel formation.
  • It is frequently associated with hemoglobinopathies, including sickle cell disease.
  • The co-occurrence of moyamoya syndrome and sickle cell trait is exceptionally rare.

Observation:

  • A 7-year-old boy presented with headaches and was diagnosed with moyamoya syndrome.
  • The patient was also found to have sickle cell trait.
  • This represents a unique pediatric presentation of this combined condition.

Findings:

  • The diagnosis of moyamoya syndrome in a child with sickle cell trait is exceedingly uncommon.
  • This case adds to the limited literature on this specific comorbidity.
  • The patient's presentation is the first reported instance in a pediatric patient.

Implications:

  • This case underscores the importance of considering moyamoya syndrome in children with sickle cell trait presenting with neurological symptoms.
  • Further research may elucidate the pathophysiological links between these conditions.
  • Early recognition and management are crucial for improving outcomes in affected children.

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Pedigree Analysis01:35

Pedigree Analysis

Overview
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...